Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

130.37
BATS BZX Real-Time Price
As of 2:59pm ET
 +2.94 / +2.31%
Today’s Change
96.93
Today|||52-Week Range
139.00
+12.63%
Year-to-Date

Today’s Trading

Previous close127.43
Today’s open128.21
Day’s range128.21 - 130.43
Volume144,835
Average volume (3 months)3,769,075
Market cap$99.7B
Dividend yield--
Data as of 2:59pm ET, 08/22/2017

Growth & Valuation

Earnings growth (last year)+28.35%
Earnings growth (this year)+23.17%
Earnings growth (next 5 years)+21.84%
Revenue growth (last year)+22.70%
P/E ratio40.5
Price/Sales8.51
Price/Book15.03

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.45+1.15%
BMYBristol-Myers Squibb+1.00+1.77%
NVONovo Nordisk+0.65+1.43%
ABBVAbbVie+1.03+1.46%
Data as of 2:59pm ET, 08/22/2017

Financials

Next reporting dateOctober 26, 2017
EPS forecast (this quarter)$1.88
Annual revenue (last year)$10.9B
Annual profit (last year)$2.0B
Net profit margin18.30%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President &
Chief Operating Officer
Scott Andrew Smith
Corporate headquarters
Summit, New Jersey

Forecasts